An analysis by Akhir et al. utilized primary murine mammary carcinoma models to demonstrate diminished tumorigenesis due to a dual C3aR/C5aR1 agonist (YSFKPMPLaR). This evidence concerns the gene C5AR1 and breast carcinoma.